96 related articles for article (PubMed ID: 4054211)
1. Stereospecific binding sites for [3H]nicotinamide adenine dinucleotide in the rat brain.
Snell PH; Snell CR; Richards CD
Eur J Pharmacol; 1985 Oct; 116(1-2):121-7. PubMed ID: 4054211
[TBL] [Abstract][Full Text] [Related]
2. Degradation of NAD by synaptosomes and its inhibition by nicotinamide mononucleotide: implications for the role of NAD as a synaptic modulator.
Snell CR; Snell PH; Richards CD
J Neurochem; 1984 Dec; 43(6):1610-5. PubMed ID: 6491670
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide adenine dinucleotide depresses synaptic transmission in the hippocampus and has specific binding sites on the synaptic membranes.
Richards CD; Snell CR; Snell PH
Br J Pharmacol; 1983 Jun; 79(2):553-64. PubMed ID: 6317113
[TBL] [Abstract][Full Text] [Related]
4. [Effect of nicotinamide adenine dinucleotide on the serotoninergic mediator system in the rat brain during 3-acetylpyridine administration].
Kuchmerovskaia TM; Chichkovskaia GV; Pakirbaeva LV; Khalmuradov AA
Vopr Med Khim; 2002; 48(3):264-70. PubMed ID: 12243084
[TBL] [Abstract][Full Text] [Related]
5. [Properties of NAD binding by synaptic membranes of rat brain].
Khalmuradov AG; Parkhomets PK; Kuchmerovskaia TM; Chichkovskaia GV
Biokhimiia; 1983 Aug; 48(8):1287-92. PubMed ID: 6626596
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.
Schäfer R; Reiser G
Br J Pharmacol; 1997 Jul; 121(5):913-22. PubMed ID: 9222547
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of crotoxin to brain synaptosomes and synaptosomal membranes.
Degn LL; Seebart CS; Kaiser II
Toxicon; 1991; 29(8):973-88. PubMed ID: 1949068
[TBL] [Abstract][Full Text] [Related]
8. Release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD⁺) in the rat brain.
Durnin L; Dai Y; Aiba I; Shuttleworth CW; Yamboliev IA; Mutafova-Yambolieva VN
Eur J Neurosci; 2012 Feb; 35(3):423-35. PubMed ID: 22276961
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes.
Bowery NG; Hill DR; Hudson AL
Br J Pharmacol; 1983 Jan; 78(1):191-206. PubMed ID: 6297646
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepine receptor: demonstration in the central nervous system.
Möhler H; Okada T
Science; 1977 Nov; 198(4319):849-51. PubMed ID: 918669
[TBL] [Abstract][Full Text] [Related]
11. Binding of nicotinamide adenine dinucleotide by the renal brush border membrane from rat kidney cortex.
Braun-Werness JL; Jackson BA; Werness PG; Dousa TP
Biochim Biophys Acta; 1983 Aug; 732(3):553-61. PubMed ID: 6871215
[TBL] [Abstract][Full Text] [Related]
12. The binding of [3H]adenosine to synaptosomal and other preparations from the mammalian brain.
Newman ME; Patel J; McIlwain H
Biochem J; 1981 Feb; 194(2):611-20. PubMed ID: 7306006
[TBL] [Abstract][Full Text] [Related]
13. Modulation by nicotinamide adenine dinucleotide of sympathetic and sensory-motor neurotransmission via P1-purinoceptors in the rat mesenteric arterial bed.
Ralevic V
Br J Pharmacol; 1995 Apr; 114(8):1541-8. PubMed ID: 7599921
[TBL] [Abstract][Full Text] [Related]
14. Biochemical characterization of putative central purinergic receptors by using 2-chloro[3H]adenosine, a stable analog of adenosine.
Williams M; Risley EA
Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6892-6. PubMed ID: 6256768
[TBL] [Abstract][Full Text] [Related]
15. [3H]2-(4-phenylpiperidino)cyclohexanol (AH5183) binding to synaptosomes and subcellular fractions obtained from rat brain.
Suzuki T; Kashima Y; Fujimoto K; Kawashima K
Neurosci Lett; 1993 Jul; 157(1):72-4. PubMed ID: 8233034
[TBL] [Abstract][Full Text] [Related]
16. Characterization of adenosine receptors in brain using N6 cyclohexyl [3H]adenosine.
Patel J; Marangos PJ; Stivers J; Goodwin FK
Brain Res; 1982 Apr; 237(1):203-14. PubMed ID: 6280803
[TBL] [Abstract][Full Text] [Related]
17. Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.
Pintor J; Díaz-Rey MA; Miras-Portugal MT
Br J Pharmacol; 1993 Apr; 108(4):1094-9. PubMed ID: 8485620
[TBL] [Abstract][Full Text] [Related]
18. [Functional-metabolic changes in the brain during various conditions of supplying the rat with vitamin PP].
Chichkovskaia GV; Parkhomets PK; Kuchmerovskaia TM; Khalmuradov AA; Donchenko GV; Rozhanskaia OP
Vopr Med Khim; 1991; 37(4):63-5. PubMed ID: 1836293
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding of DL-[3H]-2-amino-4-phosphonobutyrate to L-glutamate-sensitive sites on rat brain synaptic membranes.
Butcher SP; Collins JF; Roberts PJ
Br J Pharmacol; 1983 Oct; 80(2):355-64. PubMed ID: 6140060
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific binding of the antidepressant rolipram to brain protein structures.
Schneider HH; Schmiechen R; Brezinski M; Seidler J
Eur J Pharmacol; 1986 Aug; 127(1-2):105-15. PubMed ID: 3019721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
